Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/5/16  and contains information from public web pages and contributions from the ZoomInfo community.

Managing Partner

Phone: +44 **********  
Email: k***@***.com
Local Address:  London , United Kingdom
SV Life Sciences
1700 Owens St Ste 184
San Francisco , California 94158
United States

Company Description: SV Life Sciences is a venture capital adviser and manager that makes selected investments in entrepreneurs and management teams. SV Life Sciences provides...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • MBA
    Harvard Business School
  • first class Masters degree , Biochemistry
    University Oxford
  • M.B.A.
    Harvard Business School
  • Masters degree , Biochemistry
    Oxford University
68 Total References
Web References
Kate Bingham Managing ...
www.biocentury.com, 5 Feb 2016 [cached]
Kate Bingham Managing Partner SV Life Sciences Advisers LLP; SV Life Sciences Managers LLP
Before joining SVLS, Hamish ...
www.topivert.com, 4 Feb 2016 [cached]
Before joining SVLS, Hamish was CEO of Cambridge Antibody Technology (CAT).
...
Kate Bingham (Observer)
Kate is a Managing Partner at SV Life Sciences Advisers, LLC (SVLS). She has been responsible for many successful venture capital investments in biotechnology companies, since joining the firm in 1991. Kate currently serves as a Director of Autifony Therapeutics, Bicycle Therapeutics, Calchan and Convergence Pharmaceuticals. Previously, she worked in business development at Vertex Pharmaceuticals and at Monitor Company. She graduated from Harvard Business School with an MBA, where she was a Baker Scholar, and also holds a first class Masters degree in Biochemistry from the University Oxford.
TopiVert Pharma Limited
www.topivert.com, 10 June 2015 [cached]
Before joining SVLS, Dr Cameron was CEO of Cambridge Antibody Technology ("CAT").
...
Kate Bingham is a Managing Partner at SV Life Sciences Advisers, LLC. She joined the firm in 1991 and is focused on the biotechnology sector. She has been responsible for a number of successful venture capital investments in biotechnology companies. Previously, she worked in business development at Vertex Pharmaceuticals and at Monitor Company. She currently serves as a Director of Autifony Therapeutics Limited, Bicycle Therapeutics Limited, Calchan Holdings Limited and Convergence Pharmaceuticals Holdings Limited. She graduated from Harvard Business School with an M.B.A., where she was a Baker Scholar, and also holds a Masters degree in Biochemistry (first class) from Oxford University.
Bicycle Therapeutics Directors
bicycletherapeutics.com, 17 Jan 2016 [cached]
Kate Bingham (Director) Kate Bingham joined SVLS in 1991. Kate currently serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. She has been responsible for past investments in Alantos, Auxilium, ESBATech, EUSA, Hexagen, Kinetix, KuDOS, Leukosite, Mednova, Micromet, PowderMed and RespiVert. Current investments include Autifony, Bicycle Therapeutics, Convergence and TopiVert.
Prior to joining SVLS, Kate worked in business development for Vertex Pharmaceuticals, a biotechnology company in Cambridge (US) and at Monitor Company, a strategy consulting firm. Kate has a first class degree in Biochemistry from Oxford University and graduated from Harvard Business School with an MBA.
Kate Bingham
...
CAT was floated on the London Stock Exchange in 1997 and was responsible for the co-development of the therapeutic antibodies adalimumab/Humira and belimumab/Benlysta. CAT was acquired by AstraZeneca in 2006.
Kate Bingham Managing ...
www.medcityhq.com, 19 Oct 2015 [cached]
Kate Bingham Managing Partner, SV Life Sciences
Kate Bingham is one of the UK's leading life sciences venture capitalists. She currently serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. She has been responsible for past investments in Alantos, Auxilium, ESBATech, EUSA, Hexagen, Kinetix, KuDOS, Leukosite, Mednova, Micromet, PowderMed, RespiVert and current investments including Autifony, Bicycle, Convergence, Pulmocide, Oncoethix,TopiVert and VHSquared
Other People with the name "Bingham":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.